Oncology nurses “play a pivotal role in guiding patients” through the genetic testing process, an expert explained.
The FDA received a biologics license application for accelerated approval of RP1 plus nivolumab for advanced, pretreated ...
The FDA granted an accelerated approval to zanidatamab-hrii for previously treated, unresectable or metastatic HER2-positve ...
The FDA accepted a supplemental new drug application to darolutamide plus androgen deprivation therapy for metastatic hormone ...
Clinicians should consider a rapid taper approach for patients with cancer who exhibit repeated signs of opioid misuse, an expert said. Tapering treatment with opioids for cancer-related pain can be a ...
Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...
Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...
The FDA granted a fast track designation to ALE-P02 for patients with CLDN1-positive squamous solid tumors. The FDA granted fast track designation to ALE.P02, a anti–Claudin-1 (CLDN1) antibody-drug ...
Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...
Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...
Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback